Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond
- 21 October 2018
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 53 (10-11) , 1153-1164
Abstract
Portal hypertension (PH) is a major complication of liver cirrhosis, as it predisposes to the development of serious clinical manifestations such as ascites, hepatic encephalopathy and variceal bleeding. Till now, the measurement of hepatic vein pressure gradient (HVPG) is the gold standard method to ascertain the presence and significance of PH, as many studies have shown its correlation with the appearance of varices and the possibility of variceal bleeding. However, the invasiveness of this procedure makes it difficult to be used in daily clinical practice. Several noninvasive methods with adequate capability of evaluating liver fibrosis, including elastographic techniques, are currently used as alternatives to HVPG in order to assess the presence and the severity of PH. The aim of this paper is to express an overview of the literature about the actual role of HVPG and all available noninvasive tests on the prediction of development of PH complications, to highlight their advantages and their potential limitations, and to provide the latest trends on clinical practice.Keywords
This publication has 109 references indexed in Scilit:
- Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experienceWiener klinische Wochenschrift, 2012
- Prognostic indicators of survival in patients with compensated and decompensated cirrhosisLiver International, 2012
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageBMC Gastroenterology, 2011
- Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2009
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡Hepatology, 2007
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorsClinical Chemistry and Laboratory Medicine (CCLM), 2004
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Color Doppler findings of gastric varices compared with findings on computed tomographyJournal of Gastroenterology, 2002
- Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertensionJournal of Hepatology, 1992
- Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilatorsJournal of Hepatology, 1985